Phase 1/2 Study of Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors
Latest Information Update: 06 Sep 2024
At a glance
- Drugs Locnartecan (Primary) ; Temozolomide (Primary) ; Vincristine (Primary)
- Indications Alveolar soft part sarcoma; Ewing's sarcoma; Rhabdomyosarcoma; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 04 Sep 2024 Planned initiation date changed to 9 Sep 2024.
- 27 Aug 2024 Planned initiation date changed from 27 Aug 2024 to 1 Sep 2024.
- 22 Aug 2024 Planned initiation date changed to 27 Aug 2024.